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Abstract
Purpose: We reviewed all tumours of the sternum referred to The London Bone and Soft Tissue Tumour Service between
1956 and 1997 inclusive.
Patients and results: There were eight patients with this pathology, the male to female ratio was 3:1 and their mean age was
53 years. Of these patients, three are alive and disease free, one is alive with recurrence, and four have died, two of the conse-
quences of the disease and two of unrelated causes. Surgery is the principal treatment of these tumours both for excision and
subsequent reconstruction.
Discussion: Extended disease-free survival is possible with correct diagnosis, complete excision at the first operation, appro-
priate skeletal reconstruction, adequate skin cover and appropriate postoperative support and follow-up.
Introduction
The sternum is an unusual site for malignant bone
tumours. A retrospective study of the London Bone
Tumour  Registry  revealed  11  were  primary  bone
tumours  of  the  sternum  (excluding  bone  marrow
derived tumours) between 1956 and 1997 inclusive.
The majority of the primary bone tumours of the ster-
num  (eight  of  11)  were  chondrosarcomas.  The
results of surgical treatment of sternal chondrosarco-
mas are dependent on both grade of tumour and ade-
quacy of resection.
Patients and methods
Eight patients with chondrosarcomas of the sternum
were  registered  with  The  London  Bone  and  Soft
Tissue  Tumour  Service.  Data  was  collected  by
reviewing patients’ clinical and operative notes and
the histology report from each tumour (Table 1).
Each tumour was graded using the system accord-
ing to Enneking (Musculoskeletal Tumour Society).1
Records were assessed with respect to the age and sex
of  each  patient,  the  symptoms  experienced,  the
tumour grade, definitive treatment, reconstruction of
both bone and soft tissue and tumour recurrence.
The mean age was 53 years (range 25–79), with six
males and two females. No patients had evidence of
metastases at the time of diagnosis. There were a total
of 12 surgical procedures (excluding biopsies) to the
sternum with all patients having at least one (Table
2). The follow up ranged from 3 to 21 years.
The  assessment,  management  and  follow-up  of
patients over a period of four decades will have var-
ied. We  outline our current management protocol
later in this paper. However, despite variations over
the years, following diagnosis, tumour resection was
undertaken in all cases. 
Results
Following  radiological  imaging,  the  diagnosis  was
made by biopsy, three by needle biopsy and five by
open biopsy. In all cases, the biopsy diagnosis was
subsequently confirmed by histological analysis of the
resection  specimen.  All  chondrosarcomas  were
reported histologically as  low  grade.  The  tumours
were in the manubrium in two patients and in the
body in the other six patients. One patient (patient 7)
had an associated pathological condition, Ollier’s dis-
ease. Enneking (MSTS)1 staging of the tumours was
G1 for patient 7 and G2 for the remainder. The ster-
num is classified as an extracompartmental site for
tumour in the MSTS system1 and therefore in all
patients  the tumour site was  T2. No patients had
metastases  at  diagnosis  (M0).  This  system  stages
patient 7 as IB and the remainder as IIB (Table 1).210 R. U. Ashford et al.
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Surgical resection was in the form of wide excision1
in five of the eight patients, including all of those in
the past 14 years. Resection was less radical during
the earlier years (two of the three patients developing
local recurrence subsequently.
Following resection, three patients required tho-
racic cage reconstruction, one with a metal implant
(this  patient  subsequently  had  the  metal  plate
removed for infection), one with a mesh and one with
a  mesh–PMMA  sandwich.  The  mesh  and
mesh–PMMA  sandwich  were  secured  with  trans-
osseous non-absorbable sutures. Wide resection of
the  manubrium  necessitated  bony  reconstruction,
whereas resection of the body at most necessitated
flap reconstruction (pectoralis major advancement or
a  transverse  rectus  abdominis  musculocutaneous
(TRAM) flap). Soft tissue closure is detailed in Table
2. 
No patient in our series required ventilatory sup-
port (although facilities for this should be available).
Review  of  operative  and  pathological  reports
revealed excision to be complete in patients 3–8 (for
patient 1 the records are incomplete and patient 2
had  the  initial  surgical procedure elsewhere).  The
margins were less than 1 mm in patient 3, and 1 cm
in patient 8. In patients 5 and 6, the tumour extended
to, but did not breach the pericardium, and in patient
7 the tumour was adherent to the thymic bed, from
which it was lifted off.
At the time of writing, three patients are alive and
disease free, one is  alive  with  recurrence and four
have died, two from their tumour, two from unre-
lated causes. Of the four patients who are still alive,
three have developed recurrences or local metastases
(lung, chest and diaphragm). No patient developed
distant metastases. The two patients whose deaths
were disease related died from local recurrence.
Three patients have had further surgery for local
recurrence, consisting of radical re-excision, and in
the two patients who are still alive to date there is no
evidence of further recurrence.
Discussion
Primary malignant tumours of the sternum are rare,
and accounted for just nine of the 2004 (0.45%) of
the  primary  bone  tumours  in  the  Leeds  Bone
Tumour Registry.8
Chondrosarcoma is the most common malignant
bone tumour of the sternum, 3,6,8–11. Chondrosarco-
mas may arise de novo from normal bone or from a
pre-existing benign tumour. Only one patient in our
series  had  a  tumour  arising  in  a  benign  tumour
(patient  7)  and  this  frequency  is  similar  to  other
series.12
The London Bone and Soft Tissue Tumour Serv-
ice presents a relatively large series of chondrosarco-
mas of the sternum, a rare tumour site, covering the
last four decades. Our series also confirms the male
preponderance  demonstrated  in  previous
series3,6,9–11,13,14.
There are a multitude of causes of a localised swell-
ing of the sternum including infection, inflammation
and benign and malignant tumours.4,15,16 Differenti-
ating between benign chondral lesions and low-grade
chondrosarcoma is notoriously difficult, even for a
skilled  pathologist.  Malignant  tumours  are  most
commonly metastatic (classically from lung, breast,
thyroid or kidney in an adult and a neuroblastoma in
children).
Classically, chondrosarcoma presents with persist-
ent pain, especially at night, although in our series of
patients a mass was common. Similarly, in the series
from the Mayo Clinic2 and Nottingham,3 the pre-
senting  complaint  was  most  frequently  a  painful
mass. In spite of the fact that the sternum is relatively
subcutaneous,  there  is  still  a  delay  from  onset  of
symptoms to diagnosis, similar to other sites of chon-
drosarcomata.12
We feel appropriate management of a swelling of
the sternum is as follows. The lesion should be diag-
nosed by history and examination, followed by plain
radiographs (Fig. 1), then accurately staged by mag-
netic  resonance  imaging  (Fig.  2),  computerised
tomography of the chest and isotope bone scanning
to  identify  possible  osseous  metastases.  Accurate
Fig. 1. Lateral radiograph of the sternum demonstrating a mass 
with cortical disruption.
Fig. 2. Magnetic resonance image of a chondrosarcoma of the 
sternum.212 R. U. Ashford et al.
radiological assessment is necessary as the mass evi-
dent on examination may represent only a small part
of a much larger tumour invading the sternum. Plain
radiographs classically  demonstrate a  large,  lobu-
lated mass with cortical destruction and mottled cal-
cification. It has been stated in previous studies that
incision17 or excision3,10,11 biopsy be performed in
preference  to  needle  biopsy  of  the  tumour.  We
advocate  needle  biopsy,  with  review  of  the  his-
topathological  specimens by  an  experienced  bone
tumour pathologist,4,18
Preoperative planning of the surgical procedure is
essential.  Plastic  and  thoracic  surgical  assistance
should be available if the resection to be performed is
extensive.  Under  antibiotic  cover,  the  sternum  is
approached  via  an  elliptical  incision.  The  tumour
mass is excised en bloc. Where the tumour is in the
body of the sternum, dissection is commenced at the
xiphoid process and proceeds proximally. Where pos-
sible part of the sternum is preserved to maintain the
circumferential continuity of the thoracic cage. If the
tumour is confined to the manubrium or body, the
uninvolved  end  of  the  sternum  can  be  preserved,
enhancing stability of the chest. For the resection to
be considered an adequate wide local excision, a 2.5-
cm tumour-free margin6,21 should be achieved both
in bone and costal cartilage. The internal mammary
arteries may require ligation.
Reconstruction depends on the site of the tumour:
where the defect is in the body and small, soft tissue
reconstruction  is  all  that  is  required.  For  larger
defects there are several methods of reconstruction:
using  prolene  mesh,  metal  implants  or  combined
mesh and methyl-methacrylate bone cement.5–7
Haemostasis is secured and suction drainage used.
Primary skin closure is usually possible, but where it
is not flap or skin grafting procedures can be utilised.
In our series, both pectoralis major advancement and
TRAM flaps were utilised. The other flap often used5
is  a  latissimus  dorsi  muscle  flap.  Pectoralis  major
advancement and latissimus dorsi muscle flaps have
the  dual  advantages  of  their  blood  supplies  being
more reliable and the  muscle being more robust.5
Appropriate regular follow-up includes clinical exam-
ination, chest and lateral sternum radiographs and
further staging investigations as necessary.
Chondrosarcomas are difficult to manage, as ade-
quacy of treatment is an important determinant in
the incidence of recurrence and duration of disease-
free survival. The size of the tumour is an important
prognostic feature,  determining resectability  (even
though reconstructive techniques now enable much
larger resections to be performed). Chondrosarco-
mas  are  resistant  to  radiotherapy  and
chemotherapy6,11 and treatment depends on com-
plete surgical excision of both the tumour (resulting
in better long-term survival than limited local exci-
sion)  and  the  biopsy  tract,  without  entering  the
tumour. If the tumour is inadequately resected then
it has been shown that there is a high incidence of
recurrence (69% compared with 6% in adequately
treated patients12). We consider adequate surgery to
be  non-contaminated  wide  excision.  Inadequate
procedures are intralesional surgery, marginal exci-
sion and any contaminated procedure.12 Excision of
the biopsy tract/scar is essential if surgery is to be
considered adequate. Our 5- and 10-year overall sur-
vival  rates  of  57  and  50%  are  similar  to  those
reported in previous studies,6,11  although half the
deaths in our series were from an unrelated cause in
the more elderly patients. Repeated excision of local
recurrences are again shown to be worthwhile,3,10 as
illustrated by patient 3 who has had two re-excisions
performed and is currently free of disease. Metasta-
tectomy can also result in extended disease-free sur-
vival,  as illustrated by patient 2 who has had two
resections of metastases and is currently alive and
disease free.
The margin of resection is important. We advocate
a 2.5-cm margin where possible. Of the four patients
in our series with small disease free margins (3, 5, 6,
8), three have developed local recurrence or meta-
static disease and the fourth has died of the disease.
Wide resection of a tumour of the sternum can be
difficult, because the sternum forms a vital link in the
integrity of the chest wall. Total sternectomy has a
number of associated problems including chest wall
instability, exposure of thoracic organs and possible
paradoxical  respiration.  Reconstruction  accom-
plished using one of the options discussed earlier pre-
vents  respiratory  deficit  and  protects  mediastinal
structures.19 Maintaining the circumferential conti-
nuity of the chest avoids paradoxical motion of the
chest. 
The most important prognostic features in chond-
rosarcoma are histology (low-grade, well-differenti-
ated tumours have the best prognosis), site of origin
(tumours of the appendicular skeleton do better than
those  of  the  axial  skeleton),  adequacy  of  surgical
resection and presenting symptoms (patients present-
ing with a mass do better than those presenting with
pain).20
We conclude, therefore, that in chondrosarcoma of
the sternum, the single most important factor deter-
mining good outcome is a complete resection of the
tumour at  the  initial  surgical procedure. This  has
been shown to reduce the incidence of local recur-
rence. We also feel that, following staging investiga-
tions,  biopsy  and  definitive  surgery  for  this  rare
tumour site should be performed at a specialist refer-
ral centre. As with the management of all muscu-
loskeletal tumours we advocate a team approach. In
addition to the orthopaedic oncologist, the particular
surgical challenges of a primary sternal tumour lend
themselves to  the  involvement of  both  plastic  and
thoracic surgeons in the team. Surgery of sternum chondrosarcoma 213
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